Published in Immunity on February 01, 1998
Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med (2001) 9.70
Interferon gamma eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells. J Exp Med (2000) 2.91
Shutdown of an acute T cell immune response to viral infection is mediated by the proapoptotic Bcl-2 homology 3-only protein Bim. Proc Natl Acad Sci U S A (2003) 2.91
Stable T cell-dendritic cell interactions precede the development of both tolerance and immunity in vivo. Nat Immunol (2005) 2.89
Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation. J Clin Invest (2009) 2.75
Apoptosis regulators Fas and Bim cooperate in shutdown of chronic immune responses and prevention of autoimmunity. Immunity (2008) 2.62
Gene dosage--limiting role of Aire in thymic expression, clonal deletion, and organ-specific autoimmunity. J Exp Med (2004) 2.43
CD8(+) T-cell selection, function, and death in the primary immune response in vivo. J Clin Invest (2000) 2.19
T cell regulation as a side effect of homeostasis and competition. J Exp Med (2003) 2.15
Fas ligand, Bcl-2, granulocyte colony-stimulating factor, and p38 mitogen-activated protein kinase: Regulators of distinct cell death and survival pathways in granulocytes. J Exp Med (2000) 2.07
Peripheral deletion of autoreactive CD8 T cells by cross presentation of self-antigen occurs by a Bcl-2-inhibitable pathway mediated by Bim. J Exp Med (2002) 1.89
Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens. J Exp Med (1998) 1.83
Use of tumour-responsive T cells as cancer treatment. Lancet (2009) 1.73
Failure to censor forbidden clones of CD4 T cells in autoimmune diabetes. J Exp Med (2002) 1.58
Acquisition of selectin binding and peripheral homing properties by CD4(+) and CD8(+) T cells. J Exp Med (1999) 1.47
The peripheral deletion of autoreactive CD8+ T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1). J Exp Med (1998) 1.47
Ontogeny of T cell tolerance to peripherally expressed antigens. Proc Natl Acad Sci U S A (1999) 1.43
T cell apoptosis and reactive oxygen species. J Clin Invest (2003) 1.35
Aberrant prostaglandin synthase 2 expression defines an antigen-presenting cell defect for insulin-dependent diabetes mellitus. J Clin Invest (1999) 1.21
Raf-1 sets the threshold of Fas sensitivity by modulating Rok-alpha signaling. J Cell Biol (2005) 1.20
Unlike Th1, Th17 cells mediate sustained autoimmune inflammation and are highly resistant to restimulation-induced cell death. J Immunol (2009) 1.19
Inducible nitric oxide synthase in T cells regulates T cell death and immune memory. J Clin Invest (2004) 1.15
CD152 (CTLA-4) determines the unequal resistance of Th1 and Th2 cells against activation-induced cell death by a mechanism requiring PI3 kinase function. J Exp Med (2004) 1.12
Dichotomy between naïve and memory CD4(+) T cell responses to Fas engagement. Proc Natl Acad Sci U S A (1999) 1.06
Fas-mediated apoptosis regulates the composition of peripheral alphabeta T cell repertoire by constitutively purging out double negative T cells. PLoS One (2008) 1.05
Anti-islet autoantibodies trigger autoimmune diabetes in the presence of an increased frequency of islet-reactive CD4 T cells. Diabetes (2011) 1.04
CD28 costimulation is required for in vivo induction of peripheral tolerance in CD8 T cells. J Exp Med (2003) 1.01
Impairment of organ-specific T cell negative selection by diabetes susceptibility genes: genomic analysis by mRNA profiling. Genome Biol (2007) 0.98
The concept of space and competition in immune regulation. Immunology (2004) 0.95
Impaired T cell death and lupus-like autoimmunity in T cell-specific adapter protein-deficient mice. J Exp Med (2003) 0.94
Efficient peripheral clonal elimination of B lymphocytes in MRL/lpr mice bearing autoantibody transgenes. J Exp Med (1998) 0.92
Many checkpoints on the road to cell death: regulation of Fas-FasL interactions and Fas signaling in peripheral immune responses. Results Probl Cell Differ (2009) 0.89
Fas expression on antigen-specific T cells has costimulatory, helper, and down-regulatory functions in vivo for cytotoxic T cell responses but not for T cell-dependent B cell responses. J Immunol (2008) 0.86
Role of passive T-cell death in chronic experimental autoimmune encephalomyelitis. J Clin Invest (2000) 0.85
Impaired survival of T helper cells in the absence of CD4. Proc Natl Acad Sci U S A (2001) 0.85
Mycobacterial antigens induce apoptosis in human purified protein derivative-specific alphabeta T lymphocytes in a concentration-dependent manner. Immunology (2002) 0.81
Idd13 is involved in determining immunoregulatory DN T-cell number in NOD mice. Genes Immun (2014) 0.78
Fas (CD95/APO-1) limits the expansion of T lymphocytes in an environment of limited T-cell antigen receptor/MHC contacts. Int Immunol (2011) 0.78
Transcription factor NFAT1 controls allergic contact hypersensitivity through regulation of activation induced cell death program. Sci Rep (2016) 0.77
Apoptosis of CD4+ T cells occurs in experimental autoimmune anterior uveitis (EAAU). Clin Exp Immunol (1999) 0.76
Unusual selection and peripheral homeostasis for immunoregulatory CD4(-) CD8(-) T cells. Immunology (2013) 0.76
Findings of scientific misconduct. NIH Guide Grants Contracts (2009) 0.75
Neurogenesis in the adult human hippocampus. Nat Med (1998) 17.53
Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science (1998) 5.19
Retracted Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. Immunity (1999) 4.42
The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity (1994) 4.26
Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Genet (1997) 4.26
Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity (1997) 4.05
Survival and differentiation of adult neuronal progenitor cells transplanted to the adult brain. Proc Natl Acad Sci U S A (1995) 3.89
Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors. J Exp Med (1984) 3.36
Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: variability and stability. Virology (1992) 3.22
Multipotent progenitor cells in the adult dentate gyrus. J Neurobiol (1998) 3.15
Heterogeneity of helper/inducer T lymphocytes. I. Lymphokine production and lymphokine responsiveness. J Exp Med (1987) 3.12
Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity (1998) 3.03
Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med (1991) 3.02
Frequencies of IL-2- and IL-4-secreting T cells in naive and antigen-stimulated lymphocyte populations. J Immunol (1988) 2.94
Antigen receptor engagement delivers a stop signal to migrating T lymphocytes. Proc Natl Acad Sci U S A (1997) 2.89
IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice. Cell (1990) 2.86
Inhibition of B lymphocyte activation by interferon-gamma. J Immunol (1987) 2.80
Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J Neurochem (1997) 2.62
Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-gamma but not TH2 cytokines. Nat Immunol (2001) 2.55
CTLA-4 regulates induction of anergy in vivo. Immunity (2001) 2.39
The role of antigen-presenting B cells in T cell priming in vivo. Studies of B cell-deficient mice. J Immunol (1988) 2.39
Differentiation of adult hippocampus-derived progenitors into olfactory neurons in vivo. Nature (1996) 2.33
Functional responses and costimulator dependence of memory CD4+ T cells. J Immunol (2000) 2.17
The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity (1996) 2.14
Effects of IL-12 on helper T cell-dependent immune responses in vivo. J Immunol (1994) 2.11
Proliferation, differentiation, and long-term culture of primary hippocampal neurons. Proc Natl Acad Sci U S A (1993) 2.00
A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: implication for an escape from antibody. Virology (1993) 1.90
Heterogeneity of helper/inducer T lymphocytes. III. Responses of IL-2- and IL-4-producing (Th1 and Th2) clones to antigens presented by different accessory cells. J Immunol (1990) 1.89
B-cell stimulatory factor 1 and not interleukin 2 is the autocrine growth factor for some helper T lymphocytes. Proc Natl Acad Sci U S A (1987) 1.85
Treatment process and outcomes for managed care patients receiving new antidepressant prescriptions from psychiatrists and primary care physicians. Arch Gen Psychiatry (2001) 1.79
Retracted Autoimmunity as a consequence of retrovirus-mediated expression of C-FLIP in lymphocytes. Immunity (1999) 1.78
Heterogeneity of helper/inducer T lymphocytes. II. Effects of interleukin 4- and interleukin 2-producing T cell clones on resting B lymphocytes. J Exp Med (1988) 1.76
Avian reticuloendotheliosis virus (strain T): V. DNA polymerase. Virology (1972) 1.75
Aqueous antigens induce in vivo tolerance selectively in IL-2- and IFN-gamma-producing (Th1) cells. J Immunol (1992) 1.73
Characterization of the ileal microbiota in rejecting and nonrejecting recipients of small bowel transplants. Am J Transplant (2011) 1.67
Antigen presentation by hapten-specific B lymphocytes. II. Specificity and properties of antigen-presenting B lymphocytes, and function of immunoglobulin receptors. J Immunol (1985) 1.64
The role of CTLA-4 in regulating Th2 differentiation. J Immunol (1999) 1.62
Stability of Th1 and Th2 populations. Int Immunol (1995) 1.61
In vivo role of interleukin 4 in T cell tolerance induced by aqueous protein antigen. J Exp Med (1993) 1.57
Patterns of cytokine secretion in murine leishmaniasis: correlation with disease progression or resolution. Infect Immun (1990) 1.55
Role of interleukin 1 in the activation of T lymphocytes. Proc Natl Acad Sci U S A (1988) 1.52
The role of antibodies in the rejection and enhancement of organ allografts.?7318. Adv Immunol (1976) 1.48
Cutting edge: hierarchy of chemokine receptor and TCR signals regulating T cell migration and proliferation. J Immunol (2000) 1.44
T cell responses in calcineurin A alpha-deficient mice. J Exp Med (1996) 1.44
IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response. J Immunol (1996) 1.42
Mutations of immunoglobulin transmembrane and cytoplasmic domains: effects on intracellular signaling and antigen presentation. Cell (1990) 1.42
Effect of chlorine treatment on infectivity of hepatitis A virus. Appl Environ Microbiol (1983) 1.41
Monoclonal antibodies against rat glomerular antigens: production and specificity. Lab Invest (1983) 1.40
Apoptosis, Fas and systemic autoimmunity: the MRL-lpr/lpr model. Curr Opin Immunol (1994) 1.40
Interrelationships of surface immunoglobulin and Fc receptors on mouse B lymphocytes. J Immunol (1975) 1.38
Idiotype-specific T cell immunity. I. Generation of effector and suppressor T lymphocytes reactive with myeloma idiotypic determinants. J Immunol (1980) 1.35
Functional heterogeneity among human inducer T cell clones. J Immunol (1988) 1.34
Role of costimulators in T cell differentiation: studies using antigen-presenting cells lacking expression of CD80 or CD86. J Immunol (1997) 1.34
T-cell stimulation: an abundance of B7s. Nat Med (1999) 1.32
Functional responses and apoptosis of CD25 (IL-2R alpha)-deficient T cells expressing a transgenic antigen receptor. J Immunol (1997) 1.32
Role of Fas-mediated cell death in the regulation of immune responses. Curr Opin Immunol (1996) 1.31
Association of murine CD31 with transmigrating lymphocytes following antigenic stimulation. Am J Pathol (1992) 1.30
Immunodeficiency in graft-versus-host disease. I. Mechanism of immune suppression. J Immunol (1988) 1.30
Non-A, non-B hepatitis-related hepatocellular carcinoma in a chimpanzee. J Med Primatol (1988) 1.29
Cytokine transcriptional events during helper T cell subset differentiation. J Exp Med (1996) 1.23
The roles of CD28 and CD40 ligand in T cell activation and tolerance. J Immunol (2000) 1.20
Mature CD4+ T lymphocytes from MRL/lpr mice are resistant to receptor-mediated tolerance and apoptosis. J Immunol (1993) 1.18
Anti-CD3 antibody induces unresponsiveness to IL-2 in Th1 clones but not in Th2 clones. J Immunol (1990) 1.18
Lysophosphatidic acids. Influence on platelet aggregation and intracellular calcium flux. Am J Pathol (1979) 1.18
Inhibition of antibody production in plasmacytoma cells by antigen. Eur J Immunol (1977) 1.17
Fibroblasts genetically modified to produce nerve growth factor induce robust neuritic ingrowth after grafting to the spinal cord. Exp Neurol (1994) 1.15
Intracellular targeting of antigens internalized by membrane immunoglobulin in B lymphocytes. J Exp Med (1995) 1.15
Functional roles of Fas and Bcl-2-regulated apoptosis of T lymphocytes. J Immunol (1998) 1.14
Analysis of IL-2, IL-4, and IFN-gamma-producing cells in situ during immune responses to protein antigens. J Immunol (1993) 1.13
Retracted Role of interleukin 12 and costimulators in T cell anergy in vivo. J Exp Med (1997) 1.12
Humoral immune functions in IL-4 transgenic mice. J Immunol (1991) 1.11
Anatomy of autoantibody production: dominant localization of antibody-producing cells to T cell zones in Fas-deficient mice. Immunity (1995) 1.10
Differential effects of nuclear receptor corepressor (N-CoR) expression levels on retinoic acid receptor-mediated repression support the existence of dynamically regulated corepressor complexes. Mol Endocrinol (1997) 1.08
Functional characteristics and survival requirements of memory CD4+ T lymphocytes in vivo. J Immunol (1999) 1.08
Non-random distribution of surface immunoglobulins on murine B lymphocytes. J Immunol (1975) 1.08
Costimulator dependence of lymphokine secretion by naive and activated CD4+ T lymphocytes from TCR transgenic mice. J Immunol (1994) 1.08
Antigen presentation by hapten-specific B lymphocytes. IV. Comparative ability of B cells to present specific antigen and anti-immunoglobulin antibody. J Immunol (1987) 1.05
Signaling-defective mutants of the B lymphocyte antigen receptor fail to associate with Ig-alpha and Ig-beta/gamma. J Biol Chem (1993) 1.04
T-cell subsets: recruiting the right kind of help. Curr Biol (1997) 1.04
Cytoplasmic tail deletion converts membrane immunoglobulin to a phosphatidylinositol-linked form lacking signaling and efficient antigen internalization functions. J Biol Chem (1991) 1.03
Episomal expression of specific sense and antisense mRNAs in Leishmania amazonensis: modulation of gp63 level in promastigotes and their infection of macrophages in vitro. Infect Immun (2000) 1.03
Functional consequences of dysregulated B7-1 (CD80) and B7-2 (CD86) expression in B or T lymphocytes of transgenic mice. J Immunol (1997) 1.02
Opposing effects of oxidants and antioxidants on K+ channel activity and tone in rat vascular tissue. Exp Physiol (1995) 1.02
Immortalization of murine connective tissue-type mast cells at multiple stages of their differentiation by coculture of splenocytes with fibroblasts that produce Kirsten sarcoma virus. J Biol Chem (1988) 1.02
Expression of bcl-X(L) restores cell survival, but not proliferation off effector differentiation, in CD28-deficient T lymphocytes. J Exp Med (2000) 1.01
AAV2-mediated CLN2 gene transfer to rodent and non-human primate brain results in long-term TPP-I expression compatible with therapy for LINCL. Gene Ther (2005) 1.01
The distribution of Ia antigens on the surfaces of lymphocytes. J Immunol (1976) 1.00
Rubella and rheumatoid arthritis: hyaluronic acid and susceptibility of cultured rheumatoid synovial cells to viruses. Proc Soc Exp Biol Med (1975) 1.00
Genetic models of abnormal apoptosis in lymphocytes. Immunol Rev (1999) 0.99
Antigen receptor-mediated anergy in resting T lymphocytes and T cell clones. Correlation with lymphokine secretion patterns. J Immunol (1992) 0.99
Histologic analysis of T lymphocyte activation in reactive lymph nodes. J Immunol (1991) 0.98
Antigen presentation by hapten-specific B lymphocytes. V. Requirements for activation of antigen-presenting B cells. J Immunol (1987) 0.98
Phosphatidic acid releases calcium from a platelet membrane fraction in vitro. Prostaglandins Med (1978) 0.97
Examination of the buoyant density of hepatitis C virus by the polymerase chain reaction. J Virol Methods (1992) 0.97
Antigen-antibody complexes suppress antibody production by mouse plasmacytoma cells in vitro. Eur J Immunol (1978) 0.96
Allopurinol can act as an electron transfer agent. Is this relevant during reperfusion injury? Biochem Biophys Res Commun (1986) 0.96
Reactive oxygen species may cause myocardial reperfusion injury. Biochem Biophys Res Commun (1985) 0.95
T lymphocyte-mediated suppression of myeloma function in vitro. III. Regulation of antibody production in hybrid myeloma cells by T lymphocytes. J Exp Med (1980) 0.95
T lymphocyte-mediated suppression of myeloma function in vitro. I. Suppression by allogeneically activated T lymphocytes. J Immunol (1979) 0.95
Amyloid beta peptide alters intracellular vesicle trafficking and cholesterol homeostasis. Proc Natl Acad Sci U S A (1998) 0.95